J. David Joyner - 01 Apr 2025 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Reporting relationship: President and CEO, Director
Issuer ticker: CVS
Reported as of: 01 Apr 2025
Net transaction value: +$15,247,302
SEC form: 4
Accepted by SEC: 03 Apr 2025, 16:25:22 UTC
Prior SEC filing: 03 Mar 2025
Next SEC filing: 02 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ J. David Joyner

Key filing fact

J. David Joyner filed Form 4 for CVS HEALTH Corp (CVS) on 03 Apr 2025.

Key facts

This page summarizes J. David Joyner's Form 4 filing for CVS HEALTH Corp (CVS).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Apr 2025, 16:25.

Change

Previous filing in this sequence was filed on 03 Mar 2025.
Current net transaction value: +$15,247,302.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

This filing has been restated. Open the amended filing.

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVS transaction

Common Stock

Tax liability

Transaction value: $125,559
Shares: -1,847
Change %: -3.4%
Price: $67.98
Shares after: 51,940
Date: 01 Apr 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVS transaction Derivative

Stock Option

Award

Transaction value: $15,372,861
Shares: +226,138
Change %
Price: $67.98
Shares after: 226,138
Date: 01 Apr 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 226,138
Exercise price: $67.98
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.

Footnote F2

Option becomes exercisable in four equal annual installments, commencing 4/1/2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .